Vir Biotechnology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vir Biotechnology's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 95% to $86,180,000. The net income dropped to -$615,061,000 and profit margin reached -714%. Total operating expenses were $767,720,000.

Profit Margin

Vir Biotechnology, Inc. (NASDAQ:VIR): Profit margin
2017 149K -69.85M -46880.54%
2018 868K -115.88M -13350.69%
2019 711K -174.68M -24568.64%
2020 67.24M -298.66M -444.14%
2021 1.08B 528.58M 48.62%
2022 1.58B 515.83M 32.64%
2023 86.18M -615.06M -713.69%

VIR Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
86.18M1.58B1.08B67.24M711K868K149K
Cost of revenue
2.76M146.31M65.86M301.57M148.47M100.22M62.51M
Gross profit
83.41M1.43B1.02B-234.33M-147.76M-99.36M-62.36M
Operating exp.
Research and development
589.67M474.64M448.00M302.41M148.47M100.22M62.51M
Selling and marketing
0000000
Total operating expenses
767.72M601.08M600.45M364.22M178.69M119.56M81.64M
Operating income
-684.30M833.06M276.89M-296.98M-177.97M-118.69M-81.49M
Other income (expenses), net
56.11M-78.78M272.91M-1.63M3.45M-212K721K
Income before tax
-628.19M754.28M549.80M-298.61M-174.52M-116.36M-80.77M
Income tax expense
-13.07M238.44M21.21M54K154K-480K-10.92M
Net income
-615.06M515.83M528.58M-298.66M-174.68M-115.88M-69.85M
Earnings per share
Basic EPS
-4.593.894.07-2.51-1.62-1.2-0.72
Diluted EPS
-4.593.833.96-2.51-1.62-1.2-0.72
Data sourceData sourceData sourceData sourceData source